Primary systemic therapy of nab-paclitaxel in breast cancer patients
Not Applicable
Recruiting
- Conditions
- breast cancer
- Registration Number
- JPRN-UMIN000007724
- Lead Sponsor
- Graduate school of medicine,Chiba University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Female
- Target Recruitment
- 36
Inclusion Criteria
Not provided
Exclusion Criteria
1)Serious drug hypersensitivity 2)Other severe complications 3)Symptomatic brain metastasis 4)Active bleeding of digestive tract 5)Serious myeloablation,renal insufficciency,liver failure 6)Massive hydrothorax or ascites 7)Allergy of the Nab-paclitaxel,paclitaxelor albumin 8)Administration Pentostatin 9)Have any cances other than breast cancer 10)Active infection 11)Pregnant 12)Severe mental disorders 13)Administration steroid 14)Not suitable for participating in the study for any other reason
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Pathological complete response rate
- Secondary Outcome Measures
Name Time Method Responce rate,Histological therapeutic effect,breast conserving rate after preoperative chemotherapy,Safety